Evaluating stroke early supported discharge using cost-consequence analysis

被引:4
|
作者
Byrne, Adrian [1 ]
Chouliara, Niki [1 ]
Cameron, Trudi [1 ]
Geue, Claudia [2 ]
Lewis, Sarah [3 ]
Robinson, Thompson [4 ,5 ]
Langhorne, Peter [6 ]
Walker, Marion F. [1 ]
Fisher, Rebecca J. [1 ]
机构
[1] Univ Nottingham, Div Rehabil Ageing & Wellbeing, Nottingham, England
[2] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
[3] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[4] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[5] Univ Leicester, NIHR Biomed Res Ctr, Leicester, Leics, England
[6] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
关键词
Early supported discharge; stroke service delivery; health services research; cost-consequence analysis; evaluation; rurality; REHABILITATION; CARE; GUIDELINES;
D O I
10.1080/09638288.2021.1983043
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Purpose To evaluate different stroke early supported discharge (ESD) services in different geographical settings using cost-consequence analysis (CCA), which presents information about costs and outcomes in the form of a balance sheet. ESD is a multidisciplinary service intervention that facilitates discharge from hospital and includes delivery of stroke specialist rehabilitation at home. Materials and methods Data were collected from six purposively sampled services across the Midlands, East and North of England. All services, rural and urban, provided stroke rehabilitation to patients in their own homes. Cost data included direct and overhead costs of service provision and staff travel. Consequence data included service level adherence to an expert consensus regarding the specification of ESD service provision. Results We observed that the most rural services had the highest service cost per patient. The main costs associated with running each ESD service were staff costs. In terms of the consequences, there was a positive association between service costs per patient and greater adherence to meeting the evidence-based ESD service specification agreed by an expert panel. Conclusions This study found that rural services were associated with higher costs per patient, which in turn were associated with greater adherence to the expert consensus regarding ESD service specification. We suggest additional resources and costs are required in order for rural services to meet evidence-based criteria.
引用
收藏
页码:7127 / 7133
页数:7
相关论文
共 50 条
  • [31] COMPARATIVE COST-CONSEQUENCE ANALYSIS OF THE BIVALENT AND QUADRIVALENT VACCINES AGAINST HPV IN SPAIN
    Lopez Belmonte, J. L.
    Cortes Bordoy, J.
    Gil de Miguel, A.
    Bresse, X.
    Serip, S.
    Nieves, D.
    Bosch, X.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A408 - A408
  • [32] Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model
    Mills, Fergal P.
    Reis, Gilmar
    Wilson, Lindsay A.
    Thorlund, Kristian
    Forrest, Jamie I.
    Guo, Christina M.
    Boulware, David R.
    Mills, Edward J.
    TOGETHER Investigators
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (01): : 101 - 106
  • [33] A cost-consequence analysis of the Queensland specialist palliative rural telehealth (SPaRTa) service
    Snoswell, Centaine L.
    Smith, Anthony C.
    Grove, Graham
    Broadbent, Andrew
    Caffery, Liam J.
    Thomas, Emma
    Kelly, Jaimon
    Haydon, Helen M.
    [J]. PROGRESS IN PALLIATIVE CARE, 2024, 32 (05) : 326 - 333
  • [34] Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea
    Seungju Cha
    Minjeong Sohn
    Hyowon Yang
    Eric J. Yeh
    Ki-Hyun Baek
    Jeonghoon Ha
    Hyemin Ku
    [J]. BMC Musculoskeletal Disorders, 25
  • [35] Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost-consequence analysis
    Horgan, A. M.
    Knox, J. J.
    Liu, G.
    Sahi, C.
    Bradbury, P. A.
    Leighl, N. B.
    [J]. CURRENT ONCOLOGY, 2011, 18 (02) : E64 - E70
  • [36] COST-CONSEQUENCE ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S696 - S696
  • [37] Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea
    Cha, Seungju
    Sohn, Minjeong
    Yang, Hyowon
    Yeh, Eric J.
    Baek, Ki-Hyun
    Ha, Jeonghoon
    Ku, Hyemin
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [38] COST-CONSEQUENCE ANALYSIS OF TROPONIN T SCREENING ON THE DETECTION OF PERIOPERATIVE MYOCARDIAL ISCHEMIA
    Buse, G. A. Lurati
    Manns, B.
    Lamy, A.
    Devereaux, P.
    [J]. ANESTHESIA AND ANALGESIA, 2013, 116 : 119 - 119
  • [39] Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients
    Ramirez, Manuel G.
    Niu, Xiaoli
    Epstein, Josh
    Yang, Dongyan
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (10) : 1041 - 1046
  • [40] A comparative cost-consequence analysis of TNF antagonists in the treatment of psoriatic arthritis.
    Nosyk, B
    Guh, D
    Bansback, N
    Melilli, L
    Anis, A
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S672 - S672